1 | 1 | | 85R9724 MCK-D |
---|
2 | 2 | | By: Garcia S.B. No. 1342 |
---|
3 | 3 | | |
---|
4 | 4 | | |
---|
5 | 5 | | A BILL TO BE ENTITLED |
---|
6 | 6 | | AN ACT |
---|
7 | 7 | | relating to prohibited nonconsensual genital surgery on certain |
---|
8 | 8 | | minors with intersex traits. |
---|
9 | 9 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
---|
10 | 10 | | SECTION 1. Sections 266.001 through 266.012, Family Code, |
---|
11 | 11 | | are designated as Subchapter A, Chapter 266, Family Code, and a |
---|
12 | 12 | | heading is added to Subchapter A to read as follows: |
---|
13 | 13 | | SUBCHAPTER A. GENERAL PROVISIONS; EDUCATIONAL SERVICES; MEDICAL |
---|
14 | 14 | | CARE |
---|
15 | 15 | | SECTION 2. Chapter 266, Family Code, is amended by adding |
---|
16 | 16 | | Subchapter B to read as follows: |
---|
17 | 17 | | SUBCHAPTER B. MEDICAL PROCEDURES AND TREATMENTS RELATED TO |
---|
18 | 18 | | INTERSEX TRAITS |
---|
19 | 19 | | Sec. 266.051. DEFINITIONS. In this subchapter: |
---|
20 | 20 | | (1) "Intersex child" means an individual who is |
---|
21 | 21 | | younger than 18 years of age and either: |
---|
22 | 22 | | (A) has inborn chromosomal, gonadal, genital, or |
---|
23 | 23 | | endocrine characteristics, or a combination of those |
---|
24 | 24 | | characteristics, that are not suited to the typical definition of |
---|
25 | 25 | | male or female or are atypical for the sex assigned; or |
---|
26 | 26 | | (B) is considered by a medical professional to |
---|
27 | 27 | | have inborn chromosomal, gonadal, genital, or endocrine |
---|
28 | 28 | | characteristics that are ambiguous or atypical for the sex |
---|
29 | 29 | | assigned. |
---|
30 | 30 | | (2) "Medical procedure or treatment related to an |
---|
31 | 31 | | intersex trait" includes genital surgery, gonadal surgery, or |
---|
32 | 32 | | hormonal treatment to treat or modify an intersex trait. |
---|
33 | 33 | | (3) "Medically necessary" means a medical procedure or |
---|
34 | 34 | | treatment immediately necessary to treat an injury, illness, |
---|
35 | 35 | | disease, or condition affecting the intersex child's health that if |
---|
36 | 36 | | delayed would adversely affect the intersex child's physical |
---|
37 | 37 | | health. |
---|
38 | 38 | | Sec. 266.052. REQUIREMENTS FOR CERTAIN MEDICAL PROCEDURES |
---|
39 | 39 | | OR TREATMENTS. A physician may not perform a medical procedure or |
---|
40 | 40 | | treatment related to an intersex trait on a foster child younger |
---|
41 | 41 | | than 12 years of age unless: |
---|
42 | 42 | | (1) the procedure or treatment is medically necessary |
---|
43 | 43 | | for the physical health of the child and the department consents to |
---|
44 | 44 | | the procedure or treatment; or |
---|
45 | 45 | | (2) the procedure or treatment is not medically |
---|
46 | 46 | | necessary for the physical health of the child and a court |
---|
47 | 47 | | authorizes the procedure or treatment as provided under this |
---|
48 | 48 | | subchapter. |
---|
49 | 49 | | Sec. 266.053. COURT APPROVAL OF CERTAIN MEDICAL PROCEDURES |
---|
50 | 50 | | OR TREATMENTS. (a) If the department or an intersex child's |
---|
51 | 51 | | physician wants the child to undergo a medical procedure or |
---|
52 | 52 | | treatment related to an intersex trait that is not medically |
---|
53 | 53 | | necessary for the physical health of the child, the department or |
---|
54 | 54 | | physician may file a petition with the court having continuing |
---|
55 | 55 | | jurisdiction over the intersex child seeking court approval of the |
---|
56 | 56 | | procedure or treatment. |
---|
57 | 57 | | (b) The court shall hold a hearing to determine whether the |
---|
58 | 58 | | proposed medical procedure or treatment related to an intersex |
---|
59 | 59 | | trait is in the child's best interest. |
---|
60 | 60 | | (c) The child must be represented by an attorney at the |
---|
61 | 61 | | hearing. The attorney for the child must: |
---|
62 | 62 | | (1) possess adequate knowledge of intersex traits, the |
---|
63 | 63 | | intersex population, and the range of medical procedures or |
---|
64 | 64 | | treatments that may be pursued in connection with the child's |
---|
65 | 65 | | intersex trait, including the option to delay any procedure or |
---|
66 | 66 | | treatment; |
---|
67 | 67 | | (2) communicate with the child, to the extent possible |
---|
68 | 68 | | given the child's age, regarding: |
---|
69 | 69 | | (A) the nature of the proposed medical procedure |
---|
70 | 70 | | or treatment; |
---|
71 | 71 | | (B) the extent to which the proposed medical |
---|
72 | 72 | | procedure or treatment is irreversible; and |
---|
73 | 73 | | (C) the projected outcome of, the possible risks |
---|
74 | 74 | | associated with, and the alternatives, including delay, to the |
---|
75 | 75 | | proposed medical procedure or treatment; |
---|
76 | 76 | | (3) interview the child, to the extent possible given |
---|
77 | 77 | | the child's age, to determine the child's wishes regarding the |
---|
78 | 78 | | pursuit or delay of any proposed medical procedure or treatment; |
---|
79 | 79 | | (4) assist the child, to the extent possible given the |
---|
80 | 80 | | child's age, in assessing the child's desires related to the child's |
---|
81 | 81 | | medical care and in communicating the child's desires to the court; |
---|
82 | 82 | | and |
---|
83 | 83 | | (5) for a child younger than 12 years of age, argue |
---|
84 | 84 | | against a proposed medical procedure or treatment that is not |
---|
85 | 85 | | medically necessary for the physical health of the child. |
---|
86 | 86 | | (d) Any party to the suit may submit to the court a report or |
---|
87 | 87 | | introduce evidence from a qualified expert on: |
---|
88 | 88 | | (1) intersex traits and the intersex population in |
---|
89 | 89 | | general; |
---|
90 | 90 | | (2) the child's specific intersex traits; |
---|
91 | 91 | | (3) the range of medical procedures and treatments |
---|
92 | 92 | | that may be pursued in connection with the child's intersex traits, |
---|
93 | 93 | | including delay; |
---|
94 | 94 | | (4) the specific medical procedure or treatment |
---|
95 | 95 | | proposed for the child, including the risks and anticipated |
---|
96 | 96 | | benefits associated with the procedure or treatment and the |
---|
97 | 97 | | possibility that the child's ultimate gender identity may differ |
---|
98 | 98 | | from the sex assigned; |
---|
99 | 99 | | (5) the extent to which the medical procedure or |
---|
100 | 100 | | treatment: |
---|
101 | 101 | | (A) is irreversible; and |
---|
102 | 102 | | (B) may safely be delayed until the child is of an |
---|
103 | 103 | | age to participate in the decision-making process; |
---|
104 | 104 | | (6) the physician's responsibilities to obtain |
---|
105 | 105 | | informed consent from the child and the child's parent or guardian |
---|
106 | 106 | | and whether those responsibilities have been adequately |
---|
107 | 107 | | discharged; and |
---|
108 | 108 | | (7) the public statements of intersex individuals or |
---|
109 | 109 | | patient advocates regarding Subdivisions (1)-(6). |
---|
110 | 110 | | (e) Following the hearing, the court shall determine |
---|
111 | 111 | | whether the proposed medical procedure or treatment related to an |
---|
112 | 112 | | intersex trait is in the child's best interest and render an order |
---|
113 | 113 | | with specific findings on: |
---|
114 | 114 | | (1) whether clear and convincing evidence establishes |
---|
115 | 115 | | that the short-term or long-term physical benefits of the proposed |
---|
116 | 116 | | medical procedure or treatment outweigh the short-term or long-term |
---|
117 | 117 | | physical risks; |
---|
118 | 118 | | (2) whether clear and convincing evidence establishes |
---|
119 | 119 | | that the short-term and long-term psychological benefits of the |
---|
120 | 120 | | proposed medical procedure or treatment outweigh the short-term or |
---|
121 | 121 | | long-term psychological risks; |
---|
122 | 122 | | (3) the extent to which the proposed medical procedure |
---|
123 | 123 | | or treatment would limit the child's future options for: |
---|
124 | 124 | | (A) fertility; |
---|
125 | 125 | | (B) development or construction of |
---|
126 | 126 | | female-typical characteristics; |
---|
127 | 127 | | (C) development or construction of male-typical |
---|
128 | 128 | | characteristics; and |
---|
129 | 129 | | (D) preservation of body characteristics |
---|
130 | 130 | | unaltered by decisions the child did not initiate; and |
---|
131 | 131 | | (4) whether clear and convincing evidence establishes |
---|
132 | 132 | | that any limitation identified under Subdivision (3) is justified |
---|
133 | 133 | | by an urgent need for the proposed medical procedure or treatment. |
---|
134 | 134 | | (f) If the requirements of Sections 266.054(1) and (2) are |
---|
135 | 135 | | satisfied, the court may consider the child's consent to the |
---|
136 | 136 | | proposed medical procedure or treatment related to an intersex |
---|
137 | 137 | | trait as clear and convincing evidence for purposes of the court's |
---|
138 | 138 | | best-interest determination under Subsection (e). |
---|
139 | 139 | | Sec. 266.054. FOSTER CHILD'S CONSENT TO MEDICAL PROCEDURE |
---|
140 | 140 | | OR TREATMENT. Notwithstanding Section 32.003 or 266.004 or other |
---|
141 | 141 | | law, a foster child 12 years of age or older may consent to a medical |
---|
142 | 142 | | procedure or treatment related to an intersex trait if the child: |
---|
143 | 143 | | (1) has been evaluated by a physician and a |
---|
144 | 144 | | psychologist, both of whom have had previous experience treating |
---|
145 | 145 | | patients with intersex traits, and the physician and psychologist |
---|
146 | 146 | | determine the child has the maturity necessary to make decisions |
---|
147 | 147 | | regarding the child's medical care; and |
---|
148 | 148 | | (2) has been provided with the information necessary |
---|
149 | 149 | | to enable the child to provide voluntary and informed consent to the |
---|
150 | 150 | | proposed medical procedure or treatment, including: |
---|
151 | 151 | | (A) the nature of the proposed medical procedure |
---|
152 | 152 | | or treatment, including whether and to what extent the proposed |
---|
153 | 153 | | procedure or treatment is irreversible; |
---|
154 | 154 | | (B) the projected outcome of the proposed medical |
---|
155 | 155 | | procedure or treatment, including whether the benefits of the |
---|
156 | 156 | | procedure or treatment are medical, psychological, or social, and |
---|
157 | 157 | | the strength of the evidence supporting the claims that the |
---|
158 | 158 | | procedure or treatment provides each of those benefits; |
---|
159 | 159 | | (C) the possible risks associated with the |
---|
160 | 160 | | proposed medical procedure or treatment, including, as applicable, |
---|
161 | 161 | | loss of reproductive capacity, loss of sexual function or |
---|
162 | 162 | | sensation, and the child's ultimate gender identity differing from |
---|
163 | 163 | | the sex assigned; and |
---|
164 | 164 | | (D) the alternatives to the proposed medical |
---|
165 | 165 | | procedure or treatment, including delaying the procedure or |
---|
166 | 166 | | treatment. |
---|
167 | 167 | | SECTION 3. This Act takes effect immediately if it receives |
---|
168 | 168 | | a vote of two-thirds of all the members elected to each house, as |
---|
169 | 169 | | provided by Section 39, Article III, Texas Constitution. If this |
---|
170 | 170 | | Act does not receive the vote necessary for immediate effect, this |
---|
171 | 171 | | Act takes effect September 1, 2017. |
---|